Innovative IOP-Independent Neuroprotection and Neuroregeneration Strategies in the Pipeline for Glaucoma
While sustained reduction of intraocular pressure (IOP) has been shown to halt and/or delay the progressive death of retinal ganglion cells (RGCs) in glaucoma, there exists great interest in the development and validation of IOP-independent therapeutic strategies for neuroprotection and/or neurorege...
Saved in:
Main Author: | James C. Tsai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2020/9329310 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determinants of Intraocular Pressure (IOP) of Glaucoma Patients at Felege Hiwot Referral Hospital, Bahir Dar, Ethiopia
by: Mitiku Wale Muluneh, et al.
Published: (2021-01-01) -
A Review of Intraocular Pressure (IOP) and Axial Myopia
by: Dongyan Zhang, et al.
Published: (2022-01-01) -
Netarsudil as an Adjunctive Therapy: Efficacy and Factors Contributing to a Favorable IOP-Lowering Effect
by: Sandy Samuel, et al.
Published: (2022-01-01) -
Keratoconus Diagnosis: Validation of a Novel Parameter Set Derived from IOP-Matched Scenario
by: Dan Lin, et al.
Published: (2020-01-01) -
Innovations in Glaucoma Surgery: Improving the Results
by: Michele Figus, et al.
Published: (2016-01-01)